Dosage guidelines for Eventity: Details about its form, potency, administration methods, and additional information
In the realm of treating postmenopausal women with osteoporosis, a new medication called Evenity (romosozumab-aqqg) has been making waves. Here's what you need to know about this drug.
Evenity is a biologic drug that falls under the sclerostin inhibitors drug class. It is indicated for postmenopausal women at high risk for fracture, including those who have a history of osteoporosis-related fractures, have a T-score of -2.5 or less at the lumbar spine or femoral neck, or have a T-score between -1.0 and -2.5 with a high fracture risk by FRAX score (hip fracture risk ≥3% or major osteoporotic fracture risk ≥20%).
The recommended dosage for Evenity is 210 mg, administered by subcutaneous injection once monthly. The injections are typically delivered as two separate consecutive injections by a healthcare professional, and can be given in the abdomen, thigh, or upper arm. It's important to note that Evenity is not available in a biosimilar version.
The treatment duration for Evenity is generally limited to 12 months, as Evenity is approved for use up to one year. After this period, treatment plans are usually reassessed.
Remember, it's crucial to consult a doctor or another healthcare professional before taking any medication, as the drug information is subject to change and may not cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.
For those wondering, Evenity does not have a recommended dosage for males, as the drug hasn't been studied in males and isn't approved by the FDA to treat osteoporosis in males.
Evenity comes as a liquid solution in single-use prefilled syringes for subcutaneous injection. It's recommended to avoid injection sites that are red, discolored, tender, hard, or bruised, as well as stretch marks or scars.
Calcium and vitamin D supplements are typically recommended during Evenity treatment. If a dose of Evenity is missed, it should be rescheduled as soon as possible, with the next dose 1 month after the rescheduled dose.
The manufacturer of Evenity offers an appointment reminder program called the Bone Matters Program, which can help ensure that doses of Evenity are not missed. This can be done by setting an alarm, putting a note where visible, or downloading a reminder app.
In summary, Evenity is a promising treatment option for postmenopausal women with osteoporosis at high risk for fracture. Always consult with a healthcare professional for personalised advice and guidance.
- Evenity, a new medication, belongs to the sclerostin inhibitors drug class, specifically designed for postmenopausal women at high risk for fracture.
- The recommended dosage for Evenity is 210 mg, given as monthly subcutaneous injections in two separate doses by a healthcare professional.
- Osteoporosis treatments for men, including Evenity, have not been studied, and the drug isn't approved by the FDA for use in males.
- Calcium and vitamin D supplements are often recommended during Evenity treatment, and missed doses should be rescheduled as soon as possible, maintaining a 1-month interval between doses.
- The manufacturer of Evenity offers an appointment reminder program, called the Bone Matters Program, to help ensure that doses are not missed.
